Motus gi receives approval from the israeli ministry of health to initiate commercial sales of its pure-vu® evs system

Fort lauderdale, fla., aug. 10, 2023 (globe newswire) -- motus gi holdings, inc., (nasdaq: mots) (“motus gi” or the “company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that it has received approval from the israeli ministry of health, medical device division (known as "amar") to initiate commercial sales of the pure-vu® evs system in israel.
MOTS Ratings Summary
MOTS Quant Ranking